![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/127 | (2006.01) |
A61K 39/00 | (2006.01) | ||
A61K 48/00 | (2006.01) |
(11) | Number of the document | 2830593 |
(13) | Kind of document | T |
(96) | European patent application number | 13713356.7 |
Date of filing the European patent application | 2013-03-25 | |
(97) | Date of publication of the European application | 2015-02-04 |
(45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
(46) | Date of publication of the claims translation | 2019-06-25 |
(86) | Number | PCT/EP2013/000902 |
Date | 2013-03-25 |
(87) | Number | WO 2013/143683 |
Date | 2013-10-03 |
(30) | Number | Date | Country code |
PCT/EP2012/0013 | 2012-03-26 | WO |
(72) |
SAHIN, Ugur, DE
HAAS, Heinrich, DE
KREITER, Sebastian, DE
DIKEN, Mustafa, DE
FRITZ, Daniel, DE
MENG, Martin, DE
KRANZ, Lena, Mareen, DE
REUTER, Kerstin, DE
|
(73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
BioNTech SE , An der Goldgrube 12, 55131 Mainz, DE |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Imunoterapijai skirtos RNR kompozicijos |
RNA FORMULATION FOR IMMUNOTHERAPY |
Payment date | Validity (years) | Amount | |
2025-02-18 | 13 | 289.00 EUR |
2026-03-25 |